Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4136773 | 0.88 | PRKCA (0.43) | PRKCANPSR1KMT2AMEN1CYP2D6 | |
| SCHEMBL2546508 | 0.68 | NPSR1 (0.38) | PRKCANPSR1KMT2AMEN1CYP2C19 | |
| SCHEMBL1776577 | 0.67 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL4136815 | 0.65 | KMT2A (0.43) | PRKCAKMT2AMEN1CYP2D6CYP2C19 | |
| SCHEMBL4389248 | 0.64 | ALDH1A1 (0.41) | NPSR1KMT2AMEN1CYP2C19 | |
| SCHEMBL10324217 | 0.64 | NPSR1 (0.40) | NPSR1KMT2A | |
| SCHEMBL6346242 | 0.64 | SLC22A2 (0.39) | KMT2AMEN1CYP2D6CYP2C19 | |
| SCHEMBL28805971 | 0.63 | EPHX2 (0.37) | NPSR1 | |
| SCHEMBL178446 | 0.63 | NPSR1 (0.43) | NPSR1 | |
| SCHEMBL4136805 | 0.63 | ALDH1A1 (0.38) | PRKCANPSR1KMT2AMEN1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1930327-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | GJA1, CDH1, OR10J3 | PRKCA 3265/4885NPSR1 2690/4885KMT2A 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.